$HELE

Helen Of Troy Swings To Profit In Q1; Boosts FY27 Net Sales Outlook; Stock Up 5.6%

Helen of Troy Ltd. (HELE) reported Q1 net income of $35.76M, or $1.51 per share, versus a year-ago net loss. Adjusted earnings were $0.17 per share. Q1 net sales rose 8.2% to $402.12M. For FY2027, the company kept EPS guidance at $3.57 to $4.18 and raised net sales to $1.759B to $1.831B.

Original reporting
Published Jul 8, 2026, 12:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 8, 2026, 1:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$HELE
Bullish
medium confidence
Mentioned
$HELE
Relevance
7/10
alphai data visualization · based on rttnews.com
Decision brief

The 30-second read

$HELEBullishMed
01

Why it matters

The key new tradable input is the raised FY2027 consolidated net sales range, while EPS guidance ranges were maintained, shaping expectations for revenue growth versus margin/earnings conversion.

02

Market read

A guidance update with a pre-market stock move indicates investors are reacting to improved revenue expectations, but unchanged EPS ranges may limit further upside.

03

What to watch

Investors may focus on the Q1 adjusted EPS miss versus the prior-year quarter ($0.17 vs $0.41) and question margin normalization assumptions behind the sales raise.

Relevance 7/10Novelty 6/10Timing: pre-market reaction after Q1 results and FY27 net sales outlook raise

Background

The company reported Q1 results and discussed its FY2027 outlook, including both earnings and net sales guidance.

Company-level read

Ticker impact

$HELEBullishMedium confidence
Context

Helen of Troy reported Q1 results and raised FY2027 net sales outlook while keeping full-year earnings guidance ranges unchanged.

Expected impact

Likely supports continued upside bias versus peers, but magnitude may be capped if investors focus on unchanged EPS guidance.

Evidence & confidence

The article discloses a higher FY27 net sales range (vs prior forecast) alongside maintained EPS guidance ranges, which typically supports valuation multiples but may not drive large EPS re-rating without margin or earnings upgrades.

Market effects

Signals resilience in consumer/household brands demand expectations, potentially supportive for discretionary/consumer staples sentiment.

Primarily US-listed large-cap consumer brand sentiment; limited direct regional spillover described.

No explicit global macro or international catalyst beyond consolidated outlook.

Counterpoint

Unchanged FY27 earnings guidance implies the net sales increase may not translate into higher profitability, reducing the durability of the rally.

Key entities

  • Helen of Troy Ltd.

    Reported Q1 results and raised FY2027 consolidated net sales outlook while maintaining full-year earnings guidance ranges.

Related articles

$HELEMedAI 8/10

Helen of Troy Q1 Earnings Call Highlights

Helen of Troy (NASDAQ:HELE) reported Q1 call highlights: Beauty and Wellness sales rose 7%, with wellness growth led by Braun, Vicks, Honeywell and PUR, while some core beauty brands faced POS pressure. International sales rose 1.1% on Osprey distribution. Margins were pressured by tariffs; gross margin fell to 46%. Full-year net sales guidance raised to $1.759B-$1.831B; adjusted EPS kept at $3.25-$3.75.

$HELEMedAI 8/10

Helen of Troy (HELE) Q1 2027 Earnings Call Transcript

Helen of Troy (HELE) reported Q1 FY2027 net sales of $402.1 million, up 8.2%, with adjusted diluted EPS of $0.17. Gross margin fell to 46.0% due to tariffs and mix. The company raised full-year net sales guidance to $1.759B-$1.831B and maintained free cash flow guidance of $85M-$100M, citing Prime Day phasing and tariff refund expectations.

$HELEMedAI 8/10

Helen of Troy reports surprise profit, raises revenue outlook

Helen of Troy (HELE) reported a surprise Q1 adjusted EPS of $0.17 versus a consensus loss of $0.01, with net sales up 8.2% to $402.1M, above forecasts. It raised fiscal 2027 revenue guidance to $1.76B-$1.83B, kept adjusted EPS at $3.25-$3.75. The company cited progress on Project Pegasus and tariff-related margin pressure.